Capital Genetics

Capital Genetics presents itself as a forex and commodities broker providing trading services to both retail and institutional clients. The company claims to offer access to high liquidity and tight spreads across a variety of financial instruments, including Forex, Metals, Stocks, Indices, and Cryptocurrencies, primarily through Contracts for Difference (CFDs). Despite its UK incorporation in early 2024, the firm operates without authorization from the UK's Financial Conduct Authority (FCA) and has been flagged by several other European regulators.